Thrombosis and kidney disease in cancer: comorbidities defining a very high risk patient: A position paper from the Cancer & the Kidney International Network

2018 ◽  
Vol 2 (2-3) ◽  
pp. 37-49 ◽  
Author(s):  
Vincent Launay-Vacher ◽  
Florian Scotté ◽  
Hanno Riess ◽  
Neil Ashman ◽  
Philip McFarlane ◽  
...  

Cancer & the Kidney International Network was created in 2014. The aim was to improve the management of cancer patients by developing clinical and scientific knowledge on the main topic of cancer and the kidney. Therefore, the Cancer & the Kidney International Network created a special working group: the Thrombosis, Kidney Disease, and Cancer working Group. The first step of this force was to produce a position paper on this topic by investigating the association of chronic kidney disease and venous thromboembolism in cancer patients, focusing particularly on the anticoagulant management of patients presenting these three comorbidities. The use of low-molecular-weight heparins, vitamin K agonists and oral direct anticoagulants in cancer patients with chronic kidney disease was reviewed.

2020 ◽  
Vol 33 (3) ◽  
pp. 417-430 ◽  
Author(s):  
Roberto Pontremoli ◽  
Vincenzo Bellizzi ◽  
Stefano Bianchi ◽  
Roberto Bigazzi ◽  
Valeria Cernaro ◽  
...  

1981 ◽  
Vol 12 (1) ◽  
pp. 1-21 ◽  
Author(s):  
T. Pentikäinen ◽  
J. Rantala

The Ministry of Social Affairs and Health, being the Supervising Office of Insurance in Finland, has established a special working group to investigate the problems involved with the solvency of insurers. A report will be compiled in a near future. The capacity of risk carriers is one of the problems dealt with, and it will be preliminarily reviewed in this paper.The problem was treated by the working group parallelly by means of1. an empirical approach observing actual fluctuations in underwriting gains of insurers, and2. a theoretical approach, constructing a stochastic-dynamic model and studying its behaviour, especially its sensitivity to numerous background factors.First the methods of investigation are described and their application is then demonstrated using some numerical data. Because a comprehensive report will be published by the working group separately, only the main schedule is given. For the same reason the consideration is limited here to stochastic risks, omitting the fact that the solvency of an insurer is also jeopardized by numerous “non-stochastic” risks such as failure in investments, political interference of the authorities, mismanagement of the company, or misappropriation of its property.


2016 ◽  
Vol 29 (3) ◽  
pp. 305-328 ◽  
Author(s):  
Luigi Francesco Morrone ◽  
Pergiorgio Bolasco ◽  
Corrado Camerini ◽  
Giuseppe Cianciolo ◽  
Adamasco Cupisti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document